The study's authors noted that the ECG acquisition technology in these wearable devices appears to be quite effective. The automated algorithms, however, could still be improved. 

“Even if we compensate for the differences in population size, the U.S. is still miles ahead when it comes to total cardiomyopathy cases," explained Walter Gabriel, MPH, an epidemiologist and analyst on the report.

At TVT 2022, there was debate whether CT imaging is needed for preplanning LAA procedures, and several new devices in development were discussed.

Leadless pacemaker technology is expanding its ability to treat more patients with dual-chamber pacing.

Researchers studied data from more than three million patients, including approximately 76,000 who underwent heart surgery.

Devi Nair, MD, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit.

The study's authors reviewed data from more than 50,000 patients, presenting their findings in JACC: Clinical Electrophysiology.

A new study reveals the damage caused to cardiovascular programs by the COVID-19 pandemic will continue to accrue unless mitigation strategies are implemented quickly. The review found a number of people dying are at home from heart conditions.